treatment-resistant depression
Articles tagged with “treatment-resistant depression”
FDA Fast-Tracks Psychedelics for Depression, PTSD, and AUD
The FDA is accelerating psychedelic drug development for treatment-resistant depression, PTSD, and AUD. What it means for patients exploring ketamine therapy.
Side Effects & Dropout Rates: New Data on Ketamine for TRD
New clinical guidance on NMDA antagonist side effects and dropout rates offers practical insight for patients considering ketamine therapy for TRD.
Why Patients Quit NMDA Therapy—And What Providers Should Do
New clinical review urges faster dose optimization and earlier switching between NMDA therapies for treatment-resistant depression. Here's what it means for patients.
When to Push for Stronger TRD Treatments, Per Experts
Psychiatric Times highlights underuse of highly effective TRD treatments. Here's what this means if you or a loved one is stuck in a cycle of failed antidepressants.
NMDA Side Effects: What Dropout Rates Mean for Patients
New clinical guidance on NMDA antagonist side effects and dropout rates offers practical insights for patients considering ketamine or esketamine therapy.
Ketamine Side Effects: What New Clinical Data Reveals
New clinical analysis examines side effect profiles and discontinuation rates for ketamine and esketamine. Here's what treatment-resistant depression patients should know.
BPL-003 Shows Lasting Relief in Treatment-Resistant Depression
New phase 2a data on BPL-003 shows sustained symptom reduction in treatment-resistant depression. What patients should know about this emerging therapy.
Ketamine Side Effects: What New Data Tells Patients
A new clinical review examines side effect profiles and discontinuation rates for NMDA antagonists like ketamine and esketamine. Here's what patients should know.
Ketamine Side Effects: What New Data Means for Patients
New clinical guidance on NMDA antagonist side effects and discontinuation rates gives patients and families sharper questions to ask before starting ketamine therapy.
How Doctors Choose Ketamine vs. Other TRD Treatments
New clinical guidance explains how psychiatrists choose between esketamine, ketamine, and brain stimulation for treatment-resistant depression patients.
Esketamine's Role in Treatment-Resistant Depression Care
New clinical guidance on esketamine for treatment-resistant depression highlights patient preferences, access barriers, and rapid-acting options for suicidal depression.
New Ketamine Nasal Spray Shows Lasting Depression Relief
Phase 2a trial results for BPL-003, a ketamine-based nasal spray for treatment-resistant depression, show sustained symptom reduction. Here's what it means.
Ketamine Therapy After Medication Failure: Finding Hope When Nothing Else Works
A patient journey guide for those who have tried multiple antidepressants without success — understanding why ketamine works differently and what to expect when starting treatment after years of failed medications.
Overcoming Treatment-Resistant Depression with Ketamine Therapy
Overcoming treatment-resistant depression with ketamine — a patient journey through failed medications, finding hope, and experiencing rapid relief with ketamine.
Ketamine Therapy vs TMS: Comparing Two Breakthrough Treatments
Ketamine therapy vs TMS (transcranial magnetic stimulation) — compare how they work, their effectiveness, cost, side effects, and which may be right for you.
Ketamine Therapy vs. ECT: Comparing Two Breakthrough Depression Treatments
A patient-friendly comparison of ketamine therapy and electroconvulsive therapy (ECT) — how they work, effectiveness, side effects, cost, and which may be right for you.
Need help or want to reach readers?
Have a correction, provider question, or advertising inquiry? Reach the editorial team.